H CYTE Inc (QB) (HCYT)
USOTC
H-CYTE is a hybrid-biopharmaceutical company dedicated to developing and delivering a novel portfolio of new diagnostics, therapeutics, and medical devices from concept to commercialization. H-CYTE is a hybrid-biopharmaceutical company dedicated to developing and delivering a novel portfolio of new diagnostics, therapeutics, and medical devices from concept to commercialization.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0.949 | 2063.04347826 | 0.046 | 7 | 0.01 | 65082 | 0.04308348 | CS |
260 | 0.655 | 192.647058824 | 0.34 | 7 | 0.006 | 91422 | 0.06780961 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.